745048-13-9

Basic information

• Product Name: [{2-[2-(2-azidoethoxy)ethoxy]ethoxy}(diphenyl)methyl]benzene
• Synonyms: [{2-[2-(2-azidoethoxy)ethoxy]ethoxy}(diphenyl)methyl]benzene
• CAS NO: 745048-13-9
• Molecular Weight: 417.508
• Mol File: 745048-13-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: [{2-[2-(2-azidoethoxy)ethoxy]ethoxy}(diphenyl)methyl]benzene(CAS DataBase Reference)
• NIST Chemistry Reference: [{2-[2-(2-azidoethoxy)ethoxy]ethoxy}(diphenyl)methyl]benzene(745048-13-9)
• EPA Substance Registry System: [{2-[2-(2-azidoethoxy)ethoxy]ethoxy}(diphenyl)methyl]benzene(745048-13-9)

Safety Data

• Hazardous Substances Data: 745048-13-9(Hazardous Substances Data)

Upstream product

• 146462-59-1 1-(methylsulfonyl)-10-(triphenylcarbinyl)-1,4,7,10-tetraoxadecane 
• 76-84-6 triphenylmethyl alcohol 
• 112-27-6 2,2'-[1,2-ethanediylbis(oxy)]bisethanol 
• 133699-09-9 10,10,10-triphenyl-3,6,9-trioxadecan-1-ol 
• 76-83-5 trityl chloride 

Downstream Products

• 883992-09-4 8-trityloxy-1-{3-[1-(p-chlorobenzoyl)-5-methoxy-2-methylindol-acetamido]}-3,6-dioxaoctane 
• 198063-13-7 1-amino-8-trityloxy-3,6-dioxaoctane 
• 86520-52-7 2-[2-(2-azidoethoxy)ethoxy]ethanol 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF

The present invention relates to compounds of general formula (I) and the tautomers and the salts thereof, particularly the pharmaceutically acceptable salts thereof with inorganic or organic acids and bases, which have valuable pharmacological properties, particularly an inhibitory effect on epithelial sodium channels, the use thereof for the treatment of diseases, particularly diseases of the lungs and airways.

Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor

Following a recent description of fluorescence resonance energy transfer between enhanced green fluorescent protein (EGFP)-fused human muscarinic M1 receptors and Bodipy-labeled pirenzepine, we synthesized seven fluorescent derivatives of this antagonist in order to further characterize ligand-receptor interactions. These compounds carry Bodipy [558/568], Rhodamine Red-X [560/580], or Fluorolink Cy3 [550/570] fluorophores connected to pirenzepine through various linkers. All molecules reversibly bind with high affinity to M1 receptors (radioligand and energy transfer binding experiments) provided that the linker contains more than six atoms. The energy transfer efficiency exhibits modest variations among ligands, indicating that the distance separating EGFP from the fluorophores remains almost constant. This also supports the notion that the fluorophores may bind to the receptor protein. Kinetic analyses reveal that the dissociation of two Bodipy derivatives (10 or 12 atom long linkers) is sensitive to the presence of the allosteric modulator brucine, while that of all other molecules (15-24 atom long linkers) is not. The data favor the idea that these analogues might interact with both the acetylcholine and the brucine binding domains.